9 Meters Biopharma, Inc. (NMTRQ)
Develops injectable drugs for rare digestive diseases and short bowel syndrome.
$0.00+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+0.0%
The outlook
NMTRQ is trading near its 52-week lows at $0.0001, sitting just 18% up from its bottom. The stock shows mixed positioning relative to its moving averages and carries a bearish lean in analyst sentiment. Analyst coverage appears minimal for this micro-cap biotech name.
What’s behind the score
Price trendMixed vs its moving averages
52-week range18% of the way from its 52-week low to high
Market cap
$1,445
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—